MNG559
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
7 twins match this tumor's tissue · 3 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SJEPD001534_D1.RNA-Seq | EPN | Posterior Fossa EPN | 0.874 |
| 2 | f17e12f0-54ed-4dc2-ab7e-22a1f90e1405 | — | — | 0.864 |
| 3 | SRR6079989 | — | — | 0.862 |
| 4 | c2e34dda-0852-492e-9cde-3ff606259c12 | — | — | 0.855 |
| 5 | SJEPD001524_R1.RNA-Seq | EPN | Posterior Fossa EPN | 0.846 |
| 6 | MNG656 | — | — | 0.839 |
| 7 | SRR23303730 | — | — | 0.835 |
| 8 | TCGA-AC-A3TN-01A-11R-A22K-07 | — | B | 0.831 |
| 9 | SJEPD001520_D1.RNA-Seq | EPN | Posterior Fossa EPN | 0.824 |
| 10 | R88 | — | — | 0.816 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 18 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| MYOGENESIS | 0.301 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.257 | Remibrutinib | — uncovered |
| APICAL_SURFACE | 0.236 | Temsirolimus | — uncovered |
| COAGULATION | 0.214 | Binimetinib | — uncovered |
| APICAL_JUNCTION | 0.160 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.158 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.154 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.090 | Idelalisib | — uncovered |
| UV_RESPONSE_UP | 0.089 | Idelalisib | — uncovered |
| CHOLESTEROL_HOMEOSTASIS | 0.071 | Remibrutinib | — uncovered |
| MYC_TARGETS_V2 | 0.069 | Idelalisib | — uncovered |
| PEROXISOME | 0.058 | Idelalisib | — uncovered |
| P53_PATHWAY | 0.047 | Idelalisib | — uncovered |
| NOTCH_SIGNALING | 0.046 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.043 | Idelalisib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.037 | Inavolisib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.014 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.011 | Inavolisib | — uncovered |